Cardiff Insights | Financing the Future of Life Sciences

Navigating Biotech Investment Risks and Rewards

Apr 29, 2026

∙ Paid

Welcome to Cardiff Insights. This edition of Cardiff Insights expands on a conversation I had with PharmaFeatures last October (link). The intent is to go substantially deeper, to give founders, CEOs, and board members the institutional and research-grade perspective on what financing decisions actually entail in 2026, and to be direct about the trade-o…

Continue reading this post for free, courtesy of David H. Crean, Ph.D..

Or purchase a paid subscription.